These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1934612)

  • 1. Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiency.
    Waldmann TA
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S37-46. PubMed ID: 1934612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma.
    Waldmann TA
    J Natl Cancer Inst; 1989 Jun; 81(12):914-23. PubMed ID: 2659803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy.
    Waldmann TA
    Cancer Surv; 1989; 8(4):891-903. PubMed ID: 2701734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.
    Waldmann TA; Goldman CK
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):45-53. PubMed ID: 2683757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine receptor-directed therapy: a model of immune intervention.
    Waldmann TA; Grant A; Tendler C; Greenberg S; Goldman C; Bamford R; Junghans RP; Nelson D
    J Clin Immunol; 1990 Nov; 10(6 Suppl):19S-28S; discussion 28S-29S. PubMed ID: 2081786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multichain interleukin-2 receptor: a target for immunotherapy.
    Waldmann TA; Pastan IH; Gansow OA; Junghans RP
    Ann Intern Med; 1992 Jan; 116(2):148-60. PubMed ID: 1727619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptors for cytokines: targets for immunotherapy of leukemia/lymphoma.
    Waldmann TA
    Ann Oncol; 2000; 11 Suppl 1():101-6. PubMed ID: 10707789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting human IL-2 receptors for diagnosis and therapy.
    Nelson DL; Kurman CC
    Proc Soc Exp Biol Med; 1994 Jul; 206(3):309-11. PubMed ID: 8016170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
    Waldmann TA
    Important Adv Oncol; 1994; ():131-41. PubMed ID: 8206486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
    Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC
    Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine receptors: a target for immunotherapy of lymphomas.
    Waldmann TA
    Ann Oncol; 1994; 5 Suppl 1():13-7. PubMed ID: 8172810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.
    Junghans RP; Waldmann TA; Landolfi NF; Avdalovic NM; Schneider WP; Queen C
    Cancer Res; 1990 Mar; 50(5):1495-502. PubMed ID: 2406013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IL-2/IL-15 receptor systems: targets for immunotherapy.
    Waldmann TA
    J Clin Immunol; 2002 Mar; 22(2):51-6. PubMed ID: 11998892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA; Tsudo M
    Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA
    Environ Health Perspect; 1987 Nov; 75():11-5. PubMed ID: 2891501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin receptors in lymphoid lesions. Relevance to diagnosis, biology, and therapy.
    Strauchen JA
    Pathol Annu; 1989; 24 Pt 2():149-65. PubMed ID: 2671880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interleukin-2 receptor on malignant cells: a target for diagnosis and therapy.
    Waldmann TA
    Cell Immunol; 1986 Apr; 99(1):53-60. PubMed ID: 3019574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.
    Tsudo M; Goldman CK; Bongiovanni KF; Chan WC; Winton EF; Yagita M; Grimm EA; Waldmann TA
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5394-8. PubMed ID: 3110786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.